Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Current Pharmaceutical Design|February 4, 2025
Advances in the Synthesis and SAR of Pyrido[2,3-d]pyrimidine ScaffoldXiongpiao Wei, Dang Fan, Haifeng Dong, et al.
Molecular Therapy. Nucleic Acids|May 26, 2022
Long non-coding RNA DDX11-AS1 promotes the proliferation and migration of glioma cells by combining with HNRNPCZijin Xiang, Qiaoli Lv, Yujun Zhang, et al.
Bioscience Reports|August 1, 2020
Lnc GNG12-AS1 knockdown suppresses glioma progression through the AKT/GSK-3β/β-catenin pathwayZijin Xiang, Qiaoli Lv, Xueru Chen, et al.
Nutrition and Cancer|December 19, 2023
Nutritional Status and Incidence of Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients Treated with ChemoradiotherapyChunhong Guan, Tianzhu Lu, Zhaohui Liao, et al.
Biotechnology & Genetic Engineering Reviews|May 16, 2023
Decapping enzyme 2 is a novel immune-related biomarker that predicts poor prognosis in gliomaYuran Mei, Qiaoli Lv, Zilong Tan, et al.
Bioorganic Chemistry|January 30, 2026
ATR inhibitors: from targeting the DNA damage response to exploiting synthetic lethality-A paradigm shift in Cancer therapyXin Zhou, Qi Qin, Huizhi Yao, et al.
Cell & Bioscience|March 19, 2026
METTL3 stabilizes FASN mRNA by mediating m6A modification to promote malignant progression of diffuse large B-cell lymphomaXiangxiang Song, Yun Zhong, Nasha Yu, et al.
Archiv Der Pharmazie|February 17, 2026
Advances in Platinum(IV) Functional Axial Ligand Research: A Prospective PerspectiveZhenjie Cheng, Mei Zhu, Tianyu Wu, et al.
Discover Oncology|March 21, 2025
Progress in ubiquitination and hepatocellular carcinoma: a bibliometric analysisMing Li, Zhiliang Xu, Siqin Liang, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 6, 2026
Targeting serine synthesis pathway to reverse paclitaxel resistance in NSCLC with combination of paclitaxel and anlotinibMengting Yu, Yanyun Hong, Qingshan Pan, et al.
Pageof 4